Cytokinetics Inc ACC.23 Conference Call Transcript
Good morning, and welcome, ladies and gentlemen, to Cytokinetics' ACC '23 Conference Call. At this time, I'd like to inform you that this call is being recorded. (Operator Instructions)
I will now turn the call over to Diane Weiser, Senior Vice President of Corporate Communications and Investor Relations. Please go ahead.
Good morning, and thanks for joining us here in New Orleans and on the call today to discuss the data from Cohort 4 REDWOOD-HCM (inaudible) FOREST-HCM (inaudible) treatment of hypertrophic cardiomyopathy. Here with me today are Robert Blum, President and Chief Executive Officer, who will make opening remarks; and Fady Malik, EVP of Research and Development who will lead (inaudible). We are honored to have Dr. Ahmad Masri, Director of the Hypertrophic Cardiomyopathy Center at Oregon Health & Science University and Dr. Sara Saberi, Assistant Professor of Internal Medicine at University of Michigan Health and Frankel Cardiovascular Center, here with us to present the data.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |